Celldex Therapeutics (CLDX) Gross Profit (2010 - 2026)
Celldex Therapeutics (CLDX) posted quarterly Gross Profit of -$1.4 million for Q1 2026, up 2.04% year-over-year from -$1.4 million in Q1 2025, and down 30.35% quarter-over-quarter from -$1.1 million in Q4 2025.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Gross Profit (2010 - 2026) Analysis & Trends
Celldex Therapeutics' Gross Profit history runs 7 years deep, the most recent figure standing at -$1.4 million for Q1 2026.
- In Q1 2026, Gross Profit rose 2.04% year-over-year to -$1.4 million; the TTM figure through Mar 2026 stood at -$4.4 million (down 506.34% YoY), while the FY2025 annual figure was -$4.5 million, down 415.97% from the prior year.
- Gross Profit for Q1 2026 stood at -$1.4 million, down from -$1.1 million in the prior quarter.
- The five-year high for Gross Profit was $2.1 million in Q3 2024, with the low at -$1.5 million in Q1 2025.
- The 3-year median for Gross Profit is -$1.1 million (2025), against an average of -$498333.3.
- The sharpest annual moves came in 2025 and 2026: Gross Profit plunged 192.19% in 2025, then grew 2.04% in 2026.
- Celldex Therapeutics' Gross Profit stood at -$439000.0 in 2024, then tumbled by 152.16% to -$1.1 million in 2025, then tumbled by 30.35% to -$1.4 million in 2026.
- Business Quant data shows CLDX's Gross Profit at -$1.4 million in Q1 2026, -$1.1 million in Q4 2025, and -$1.1 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn |
| 10 | Celldex Therapeutics | 3.07 Bn | 3.07 Bn | -2.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.57 Mn |
| Mar 31, 2026 | -1.44 Mn |
| Dec 31, 2025 | -1.11 Mn |
| Sep 30, 2025 | -1.06 Mn |
| Jun 30, 2025 | -814,000.00 |
| Mar 31, 2025 | -1.47 Mn |
| Dec 31, 2024 | -439,000.00 |
| Sep 30, 2024 | 2.12 Mn |
| Jun 30, 2024 | 883,000.00 |
| Mar 31, 2024 | -1.15 Mn |
| Dec 31, 2013 | 620,000.00 |
| Sep 30, 2013 | 980,000.00 |
| Jun 30, 2013 | 97,000.00 |
| Mar 31, 2013 | 80,000.00 |
| Dec 31, 2012 | 96,000.00 |
| Sep 30, 2012 | 107,000.00 |
| Jun 30, 2012 | 136,000.00 |
| Mar 31, 2012 | 89,000.00 |
| Dec 31, 2011 | 75,000.00 |
| Sep 30, 2011 | 45,000.00 |